Ke Zhang

Dr. Ke Zhang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2024 in Journal of Controlled Release
Verified
Journal Article
Closed access
FAFeng Ao
Feng Ao
XLXi Li
Xi Li
YTYan Tan
Yan Tan
ZJZebo Jiang
Zebo Jiang
FYFan Yang
Fan Yang
DLDan Li
Dan Li

25 January 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JLJunfeng Liu
Junfeng Liu
XLXi Li
Xi Li
JCJiayao Chen
Jiayao Chen
XZXiaoting Zhang
Xiaoting Zhang
JGJingpei Guo
Jingpei Guo
BZBin Zhou
Bin Zhou

2 September 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JLJiani Liu
Jiani Liu
JCJiayao Chen
Jiayao Chen
HLHongxing Liu
Hongxing Liu
KZKe Zhang
Ke Zhang
QZQi Zeng
Qi Zeng
HSHong Shan
Hong Shan

12 January 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
RWRuixue Wei
Ruixue Wei
KLKun Liu
Kun Liu
KZKe Zhang
Ke Zhang
YFYifan Fan
Yifan Fan
HLHongyu Lin
Hongyu Lin
JGJinhao Gao
Jinhao Gao

30 November 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
KZKe Zhang
Ke Zhang
DLDan Li
Dan Li
BZBin Zhou
Bin Zhou
JLJiani Liu
Jiani Liu
XLXiangjie Luo
Xiangjie Luo
HSHong Shan
Hong Shan
Arsenic trioxide (ATO, As2O3), an active ingredient of traditional Chinese medicine, has been approved by the U.S. Food and Drug Administration as an effective therapeutic agent for acute promyelocytic leukemia (APL).

11 July 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JLJunbin Liu
Junbin Liu
XZXiaoting Zhang
Xiaoting Zhang
JGJingpei Guo
Jingpei Guo
YZYun Zhang
Yun Zhang
JFJinming Fan
Jinming Fan
BZBin Zhou
Bin Zhou
Introduction: Neuroinflammation is a pivotal factor in the pathophysiology process of ischemic stroke. Undue inflammatory responses are the main cause of neuronal death and infarct enlargement after reperfusion, but there is currently no effective clinical treatment method. Pyroptosis plays an important role in post-stroke neuroinflammation. Inhibiting pyroptosis may be a potential method for treating ischemic stroke. Ursolic acid (UA) is a natural antioxidant with an antipyroptotic effect, but the mechanism of UA in cerebral ischemia-reperfusion injury remains unknown.Methods: We evaluated UA’s neuroprotective effects in a transient middle cerebral artery occlusion (tMCAO) mouse model via oral administration. TTC staining was carried out to measure infarct volume. Neuronal damage was assessed through TUNEL and FJC staining. Open field test and novel object recognition test were conducted to evaluate anxiety-like behavior and hippocampal-related memory. Double-immunofluorescence was conducted to detect pyroptotic microglia. In vitro, BV-2 microglial cells subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) were treated with UA. Cell viability was measured utilizing CCK-8 assay. RT-qPCR was used to measure NLRP3, IL-1β, and IL-18 mRNA levels. ELISA was utilized to measure IL-1β and IL-18 concentration. PMA was used as an agonist in rescue experiment. Immunostaining was used to observe nuclear/cytoplasmic distribution of NF-κB. Western blot was used to evaluate the protein expression of pyroptosis markers.Results: UA significantly reduced infarct volume, alleviated neuronal damage, and improved cognitive and functional recovery in tMCAO mice. Additionally, UA downregulated the density of NLRP3, Caspase-1, and GSDMD positive microglia and the production of IL-1β and IL-18 in the ischemic penumbra of tMCAO mice. These effects were replicated in OGD/R-challenged BV-2 cells. Mechanistically, UA suppressed NF-κB activation, and PMA treatment reversed its therapeutic benefits in both models.Discussion: Our findings demonstrate that UA attenuates microglial pyroptosis by inhibiting NF-κB signaling, thereby reducing neuroinflammation and ischemic brain injury. This study highlights UA’s potential as a therapeutic agent for ischemic stroke.